Literature DB >> 20732605

Association between clinical examination and outcome after cardiac arrest.

Jon C Rittenberger1, John Sangl, Matthew Wheeler, Francis X Guyette, Clifton W Callaway.   

Abstract

BACKGROUND: Neurologic prognostication after cardiac arrest relies on clinical examination findings derived before the advent of therapeutic hypothermia (TH). We measured the association between clinical examination findings at hospital arrival, 24, and 72 h after cardiac arrest in a modern intensive care unit setting.
METHODS: Between 1/1/2005 and 3/31/2009, hospital charts were reviewed in 272 subjects for neurologic examination findings (Glasgow Coma Score--motor examination, pupil response, corneal response) at hospital arrival, 24, and 72 h following cardiac arrest. Primary outcome was survival to hospital discharge. Secondary outcome was "good outcome," defined as discharge to home or acute rehabilitation facility.
RESULTS: Mean age was 61 years; 155 (57%) were male. Most were treated with TH (N=161; 59%) and 100 subjects (37%) were in ventricular fibrillation/ventricular tachycardia. Out-of-hospital cardiac arrest was common (N=169; 62%). Ninety-one (33%) survived, with 54 (20%) experiencing a good outcome. In subjects with a GCS Motor score < or = 3 at 24 and 72 h survival was 17% (13/76; 95% CI 7.9-26.2%) and 20% (6/27; 95% CI 6.3-33.6%), respectively. Subjects with a GCS Motor score < or = 2 at 24 and 72 h survived in 14% (9/66; 95% CI 4.6-22.6%) and 18% (6/33; 95% CI 3.5-32.8%), respectively. Absent pupil reactivity on arrival did not exclude survival (7/65; 11%; 95% CI 2.4-19%). A lack of pupil reactivity or corneal response at 72 h was associated with death (pupil: 0/17; 95% CI 0, 2.9%; corneal: 0/21; 95% CI 0, 2.4%).
CONCLUSIONS: GCS Motor score < or = 3 or < or = 2 at 24 or 72 h following cardiac arrest does not exclude survival or good outcome. However, absent pupil or corneal response at 72 h appears to exclude survival and good outcome. Copyright 2010 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20732605      PMCID: PMC2925188          DOI: 10.1016/j.resuscitation.2010.05.011

Source DB:  PubMed          Journal:  Resuscitation        ISSN: 0300-9572            Impact factor:   5.262


  18 in total

1.  Mild therapeutic hypothermia to improve the neurologic outcome after cardiac arrest.

Authors: 
Journal:  N Engl J Med       Date:  2002-02-21       Impact factor: 91.245

2.  Treatment of comatose survivors of out-of-hospital cardiac arrest with induced hypothermia.

Authors:  Stephen A Bernard; Timothy W Gray; Michael D Buist; Bruce M Jones; William Silvester; Geoff Gutteridge; Karen Smith
Journal:  N Engl J Med       Date:  2002-02-21       Impact factor: 91.245

3.  Predictors of awakening from postanoxic status epilepticus after therapeutic hypothermia.

Authors:  Andrea O Rossetti; Mauro Oddo; Lucas Liaudet; Peter W Kaplan
Journal:  Neurology       Date:  2009-02-24       Impact factor: 9.910

4.  Outcomes of a hospital-wide plan to improve care of comatose survivors of cardiac arrest.

Authors:  Jon C Rittenberger; Francis X Guyette; Samuel A Tisherman; Michael A DeVita; Rene J Alvarez; Clifton W Callaway
Journal:  Resuscitation       Date:  2008-11       Impact factor: 5.262

5.  Regional variation in out-of-hospital cardiac arrest incidence and outcome.

Authors:  Graham Nichol; Elizabeth Thomas; Clifton W Callaway; Jerris Hedges; Judy L Powell; Tom P Aufderheide; Tom Rea; Robert Lowe; Todd Brown; John Dreyer; Dan Davis; Ahamed Idris; Ian Stiell
Journal:  JAMA       Date:  2008-09-24       Impact factor: 56.272

6.  Predictors of poor neurologic outcome after induced mild hypothermia following cardiac arrest.

Authors:  E Al Thenayan; M Savard; M Sharpe; L Norton; B Young
Journal:  Neurology       Date:  2008-11-04       Impact factor: 9.910

Review 7.  Is this patient dead, vegetative, or severely neurologically impaired? Assessing outcome for comatose survivors of cardiac arrest.

Authors:  Christopher M Booth; Robert H Boone; George Tomlinson; Allan S Detsky
Journal:  JAMA       Date:  2004-02-18       Impact factor: 56.272

8.  Diffusion and perfusion MRI of the brain in comatose patients treated with mild hypothermia after cardiac arrest: a prospective observational study.

Authors:  Hanna Järnum; Linda Knutsson; Malin Rundgren; Roger Siemund; Elisabet Englund; Hans Friberg; Elna-Marie Larsson
Journal:  Resuscitation       Date:  2009-02-10       Impact factor: 5.262

9.  Prognostic value of brain diffusion-weighted imaging after cardiac arrest.

Authors:  Christine A C Wijman; Michael Mlynash; Anna Finley Caulfield; Amie W Hsia; Irina Eyngorn; Roland Bammer; Nancy Fischbein; Gregory W Albers; Michael Moseley
Journal:  Ann Neurol       Date:  2009-04       Impact factor: 10.422

10.  Comatose patients with cardiac arrest: predicting clinical outcome with diffusion-weighted MR imaging.

Authors:  Ona Wu; A Gregory Sorensen; Thomas Benner; Aneesh B Singhal; Karen L Furie; David M Greer
Journal:  Radiology       Date:  2009-05-06       Impact factor: 11.105

View more
  14 in total

1.  An early, novel illness severity score to predict outcome after cardiac arrest.

Authors:  Jon C Rittenberger; Samuel A Tisherman; Margo B Holm; Francis X Guyette; Clifton W Callaway
Journal:  Resuscitation       Date:  2011-07-05       Impact factor: 5.262

2.  Validation of the Pittsburgh Cardiac Arrest Category illness severity score.

Authors:  Patrick J Coppler; Jonathan Elmer; Luis Calderon; Alexa Sabedra; Ankur A Doshi; Clifton W Callaway; Jon C Rittenberger; Cameron Dezfulian
Journal:  Resuscitation       Date:  2015-01-28       Impact factor: 5.262

3.  Awakening and withdrawal of life-sustaining treatment in cardiac arrest survivors treated with therapeutic hypothermia*.

Authors:  Maximilian Mulder; Haley G Gibbs; Stephen W Smith; Ramnik Dhaliwal; Nathaniel L Scott; Mark D Sprenkle; Romergryko G Geocadin
Journal:  Crit Care Med       Date:  2014-12       Impact factor: 7.598

4.  Combination of initial neurologic examination, quantitative brain imaging and electroencephalography to predict outcome after cardiac arrest.

Authors:  Chun Song Youn; Clifton W Callaway; Jon C Rittenberger
Journal:  Resuscitation       Date:  2016-11-10       Impact factor: 5.262

5.  Combining NSE and S100B with clinical examination findings to predict survival after resuscitation from cardiac arrest.

Authors:  Luis M Calderon; Francis X Guyette; Ankur A Doshi; Clifton W Callaway; Jon C Rittenberger
Journal:  Resuscitation       Date:  2014-04-30       Impact factor: 5.262

6.  Timing of neuroprognostication in postcardiac arrest therapeutic hypothermia*.

Authors:  Sarah M Perman; James N Kirkpatrick; Angelique M Reitsma; David F Gaieski; Bonnie Lau; Thomas M Smith; Marion Leary; Barry D Fuchs; Joshua M Levine; Benjamin S Abella; Lance B Becker; Raina M Merchant
Journal:  Crit Care Med       Date:  2012-03       Impact factor: 7.598

7.  Continuous EEG monitoring enhances multimodal outcome prediction in hypoxic-ischemic brain injury.

Authors:  Edilberto Amorim; Jon C Rittenberger; Julia J Zheng; M Brandon Westover; Maria E Baldwin; Clifton W Callaway; Alexandra Popescu
Journal:  Resuscitation       Date:  2016-08-21       Impact factor: 5.262

8.  Distinct predictive values of current neuroprognostic guidelines in post-cardiac arrest patients.

Authors:  Sonya E Zhou; Carolina B Maciel; Cora H Ormseth; Rachel Beekman; Emily J Gilmore; David M Greer
Journal:  Resuscitation       Date:  2019-04-02       Impact factor: 5.262

9.  Cerebral performance category at hospital discharge predicts long-term survival of cardiac arrest survivors receiving targeted temperature management*.

Authors:  Cindy H Hsu; Jiaqi Li; Marisa J Cinousis; Kelsey R Sheak; David F Gaieski; Benjamin S Abella; Marion Leary
Journal:  Crit Care Med       Date:  2014-12       Impact factor: 7.598

10.  Duration of resuscitation efforts and functional outcome after out-of-hospital cardiac arrest: when should we change to novel therapies?

Authors:  Joshua C Reynolds; Adam Frisch; Jon C Rittenberger; Clifton W Callaway
Journal:  Circulation       Date:  2013-11-17       Impact factor: 29.690

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.